Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

ILC1-like cells can cause alopecia areata by themselves.

More research is needed to understand and manage rheumatoid arthritis better.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

HIV patients with lower CD4 T cell counts often have more skin problems.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Special cells can help regrow hair in alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Dupilumab for skin problems might reactivate hair loss in some patients.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.